Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-02-23
1998-12-29
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 31505
Patent
active
058542388
ABSTRACT:
treatment and prevention of illnesses which are caused by low plasma apolipoprotein A-I levels as coronary coronary disease.
REFERENCES:
patent: 4155913 (1979-05-01), Hellerbach et al.
Tahara et al., Chem. Pharm. Bull., 35(5), 2119-21 (abstract), 1987.
Kwiterovich et al., Am J. Cardiology, 69:1015-21, Apr. 15, 1992.
Epstein William H.
Hoffmann-La Roche Inc.
Johnston George W.
Parise John P.
Spivack Phyllis G.
LandOfFree
Use of a thienotriazolodiazephine to increase apolipoprotein A-I does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a thienotriazolodiazephine to increase apolipoprotein A-I, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a thienotriazolodiazephine to increase apolipoprotein A-I will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1425020